Thus, this work aimed to apply these hybrid nanoparticles to deliver siRNA molecules to human breast cancer tumors in nude mice and assess the effects of HOXB7 gene silencing with and without TMX cotreatment in vivo. Here, HOXB7 is linked to breast carcinoma.